This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Tuberculosis


  • How to Evaluate Respirators
    ICT introduces a new, regular column in which members of industry suggest strategies for the evaluation and purchasing of infection prevention and control products. This month we take a look at respirators. Participants: — Grant Rowe, product manager for respiratory ...More
    January 29, 2009 Posted in Articles, PPE & Standard Precautions
  • New Treatment Option for Latent Tuberculosis
    Patients who are infected with the latent form of tuberculosis (TB) show no symptoms and are not contagious, yet they pose the biggest challenge when it comes to controlling the disease. The latest study by Dr. Dick Menzies of the Research Institute of the McGill University ...More
    January 22, 2009 Posted in News
  • EPA Accepts New Claims for a PDI Germicidal Wipe
    Professional Disposables International, Inc. (PDI), a leading manufacturer of pre-moistened wipes for healthcare, recently received Environmental Protection Agency (EPA) acceptance to include three additional microorganisms to Super Sani-Cloth® Germicidal Disposable ...More
    January 15, 2009 Posted in News, Environmental Hygiene
  • Tuberculosis Bacteria Co-Opt Body's Defenses to Gain Foothold
    Tuberculosis bacteria can commandeer the body's defenses in the early stages of infection and redirect them for their own offensive strategies, according to results reported today in the scientific journal Cell.The dense granulomas characteristic of TB were originally ...More
    January 9, 2009 Posted in News, Hand Hygiene, PPE & Standard Precautions
  • Global Health Should be Key Component of U.S. Foreign Policy
    The U.S. should significantly intensify its commitment to global health in the next four years by increasing funding and placing greater importance on health when setting overall U.S. foreign policy, says a new report from the Institute of Medicine written to inform the ...More
    December 15, 2008 Posted in News
  • Experimental TB Drug Explodes Bacteria from the Inside Out
    An international team of biochemists has discovered how an experimental drug unleashes its destructive force inside the bacteria that cause tuberculosis (TB). The finding could help scientists develop ways to treat dormant TB infections, and suggests a strategy for drug ...More
    December 1, 2008 Posted in News
  • Report Shows Growing Industry Effort on “Most Neglected” Diseases
    The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) has published a new edition of its Status Report on Pharmaceutical Industry R&D for Diseases of the Developing World. The new report shows that the number of medicine and vaccine ...More
    November 21, 2008 Posted in News
  • Study Shows Declining Number of Cases of XDR-TB
    CHICAGO – A new report suggests that the number of cases of extensively drug-resistant tuberculosis (XDR-TB) in the U.S. has declined in the past 15 years, but new cases continue to be reported, according to the study published in the Nov. 12 issue of JAMA. The ...More
    November 13, 2008 Posted in News
  • XDR-TB: Deadlier and More Mysterious Than Ever
    New research has found that XDR-TB is increasingly common and more deadly than previously known. Extensively drug-resistant tuberculosis (XDR-TB) is a growing public health threat that is only just beginning to be understood by medical and public health officials. Patients ...More
    November 6, 2008 Posted in News
  • Persistent Bacterial Infection Exploits Killing Machinery of Immune Cells
    A new study reveals an important and newly discovered pathway used by disease-causing bacteria to evade the host immune system and survive and grow within the very cells meant to destroy them. This discovery may lead to new treatments and vaccines for tuberculosis (TB) and ...More
    November 3, 2008 Posted in News